News for the Multiple Sclerosis Community

User login

Welcome to MSNews

Who's online

There are currently 0 users and 2 guests online.

Older Articles

Older Articles

Other Sites For MS News

Thanks

Site implementation:
Jaspan Consulting

Graphic design:
Clockwork Design Group, Inc.

The MSNews web site is
Powered by Drupal

Home

Remyelination Drug

Submitted by art on Fri, 2006-02-24 08:09.

Xanthus Life Sciences, Inc., announced that data from a study conducted with a Multiple Sclerosis (MS) animal model demonstrated that Symadex(TM) permitted remyelination by prevention of inflammatory cell infiltration.

It seems it is similar to Novantrone, but with fewer negative side-effects.

Oops

Submitted by Jayne on Thu, 2006-03-02 10:49.
My comment is that we are in a real quandry. I hadn't wanted to try Novantrone since I am /was stable with Betaseron but I worry about my future as I believe I am genetically wired to acquire MS and I rejected the idea of a chemotherapeutic agent. Was my initial impulse wrong? I'm currently planning to begin Tysabri hen it comes back on the market this Spring. Still I'm a little unsure. Am I making the right move?
»

Will ask Dr Macaluso about this

Submitted by Jayne on Sun, 2006-03-05 16:08.
Either by phone or when I see him next which will be in April.
»

very interesting

Submitted by Jayne on Mon, 2006-02-27 12:27.
I'm still in my cyberhell but I thought I'd remark on this.
»
Find Out More About Accelerated Cure Project